Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Blood and saliva markers to track gum disease and healing after non-surgical cleaning

Official title: The Relationship of HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 Levels With Periodontal Disease and Healing After Non-Surgical Periodontal Therapy

Run by Erzincan University · NCT07312045 · Data updated 2026-11-12

This project tries to see if a blood score (HALP), other blood inflammation markers, and salivary MMP-8 can help identify gum disease stage and predict healing after non-surgical periodontal cleaning in adults aged 18–65.

More Periodontitis trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment180 (estimated)
SponsorErzincan University
Academic / other
Locations1 site (Merkez, Erzincan)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedNovember 25, 2026
Study endsNovember 25, 2026
Registry record updatedDecember 31, 2025
Trial IDNCT07312045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with healthy gums, gingivitis, or stage III/IV periodontitis who are non-smokers, free of systemic conditions that affect periodontal health, and willing to attend in-person follow-up visits.

Probably not a fit

People with systemic inflammatory diseases (for example diabetes or autoimmune disorders), current smokers, pregnant or lactating individuals, or those on recent antibiotics/anti‑inflammatory or immunosuppressive drugs are excluded and may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study that will enroll 180 adults split into healthy, gingivitis, and stage III/IV periodontitis groups. All participants receive a periodontal exam and provide blood and saliva samples at baseline to measure the HALP score, NLR, PLR, LMR, SII, and salivary MMP‑8. Participants with gingivitis or periodontitis receive standard non-surgical periodontal therapy (full-mouth debridement) and return for repeat periodontal measurements at 3 months, with an additional blood draw planned for the periodontitis group if feasible. Biomarker levels will be compared across groups and related to clinical healing after treatment.

Why it matters

Potential benefit: If successful, readily available blood and saliva tests could help clinicians stage gum disease and predict which patients will respond well to non-surgical therapy.

How similar studies have gone: Previous research has shown that blood markers like NLR/PLR and salivary MMP‑8 relate to periodontal inflammation, but applying the composite HALP score to periodontal staging and healing is a relatively new approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-65 years
* Ability to provide informed consent
* No systemic diseases or conditions affecting periodontal status
* For Healthy Group: Probing depth ≤3 mm, no attachment loss, no radiographic bone loss
* For Gingivitis Group: Gingival inflammation and bleeding on probing without attachment loss or bone loss
* For Periodontitis Group: Stage III or stage IV periodontitis according to 2018 classification
* No periodontal treatment within the past 6 months
* Willingness to attend follow-up visits

Exclusion Criteria:

* Systemic diseases influencing periodontal inflammation (e.g., diabetes, autoimmune disorders)
* Current pregnancy or lactation
* Use of antibiotics, anti-inflammatory medications, or immunosuppressive drugs within the last 3 months
* Smokers or individuals using tobacco products
* History of periodontal surgery in the last 6 months
* Presence of fewer than 20 natural teeth
* Any condition that may interfere with study participation or data reliability

Where it's running

  • Erzincan Binali Yıldırım University Faculty of Dentistry
    Merkez, Erzincan, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.